This inventor holds 1 USPTO granted patent. Top assignee: Nihon Chemical Research Co., Ltd.. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: Koichi Sugita: Innovator in Injection Syringe Technology
Introduction
Koichi Sugita is a notable inventor based in Takarazuka, Japan. He has made significant contributions to the field of medical devices, particularly in the design of injection syringes. His innovative approach addresses critical issues related to the stability of sensitive medications.
Latest Patents
Sugita holds a patent for an "Injection syringe including device for preparation of injection." This invention is particularly useful for medications that are prone to chemical changes when left in solution or dispersion for extended periods. The syringe is designed to be portable, allowing patients to prepare their injections on-site. It features a device that automatically administers a prescribed dosage, minimizing mechanical impacts that could affect the medication's integrity. This syringe is especially beneficial for administering human growth hormones, interferon, and various polypeptides that are sensitive to environmental conditions.
Career Highlights
Throughout his career, Koichi Sugita has been associated with Nihon Chemical Research Co., Ltd. His work has focused on developing innovative solutions that enhance the safety and efficacy of medical treatments. Sugita's dedication to improving patient care through technology is evident in his patented designs.
Collaborations
Sugita has collaborated with notable colleagues, including Sei Kirihara and Hiromichi Ishikawa. Their combined expertise has contributed to advancements in the field of medical devices.
Conclusion
Koichi Sugita's contributions to injection syringe technology demonstrate his commitment to innovation in healthcare. His patented designs not only improve the administration of sensitive medications but also enhance patient convenience and safety.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile